Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

NCT: NCT06310031 · RECRUITING

NCT IDNCT06310031
StatusRECRUITING
Start Date2024-10-28
Completion2028-12

Brief Summary

The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

Frequently Asked Questions

What is Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure?

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure is a clinical trial registered under NCT06310031. Current status: RECRUITING.

What is the status of NCT06310031?

The current status of NCT06310031 (Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure) is: RECRUITING.

When did Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure start?

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure started on 2024-10-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑